EN DE

XIIlab Co (189330) Fair Value & Analysis

Technology · KR · Market cap 82.8B KRW

XC XIIlab Co 189330 · KQ
Price13,810 KRW
Fair Value2,495 KRW
Upside-81.9%
Quality36/100
Watch XIIlab Co for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -38.1% net margin
negative free cash flow
Trails peers (1/7)
Narrow moat 9/100
Evidence: Low Range 1,646 KRW – 3,118 KRW Share as image

Fair value as of: Jul 20, 2026

From 1 valuation models · updated 20 days ago

Share price +12.9% over the past month.

Below-average quality, and screening another 82% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (3,118 KRW). The favourable scenario is already priced in.
  • Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • A fairly wide model range (1,646 KRW to 3,118 KRW) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

60,734 KRW 3,475 KRW Fair Value 2,495 KRW Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.

How to read this chart

60‑month range 3,475 KRW – 60,734 KRW · fair‑value band 1,646 KRW – 3,118 KRW · the 13,810 KRW price screens above the 2,495 KRW fair value. Dashed = 300-day average. As of Jul 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

XIIlab Co (189330) currently trades at 13,810 KRW, while our model-based Fair Value estimate is 2,495 KRW, implying the stock looks roughly 81.9% overvalued today. The Quality Score stands at 36/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, XIIlab Co generated revenue of 10.6B KRW at a net margin of -38.1%. Revenue grew 41.8% year over year. It earns a return on equity of -25.1%. Fundamentals as of Jul 20, 2026

Our scenario range runs from 1,646 KRW (bear case) to 3,118 KRW (bull case); at 13,810 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 306% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at -25% fair-value upside, at -82%, 189330 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) 1,339 KRW 1,794 KRW 2,678 KRW 50
All 1 models by family
Asset-Based
NCAV (Graham) 1,339 KRW 1,794 KRW 2,678 KRW 50

Notify me when 189330 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 10.6B KRW
Revenue growth (YoY) +41.8%
Net margin -38.1%
Return on equity -25.1%
Free cash flow −1.4B KRW FY2025
Operating margin -173%

Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 36/100

Of which business quality 39 · Market factors (momentum, volatility) 73

Profitability 7
Margins and returns on capital today
Quality Growth 65
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 98
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 16
Calm price path (market factor)
Momentum 100
Price trend over the last 3–12 months (market factor)
52W Momentum 91
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

XIIlab Co.,Ltd provides data-driven AI video analysis services in South Korea. It offers X-AIVA, an AI video analysis platform; Uyuni, an AI standard platform based on Kubenetes; X-Labeller, a video data processing solution; X-GEN, a synthetic data generation solution; and Vidigo, a cloud-based AI video and speech analysis service.

Full company description

XIIlab Co.,Ltd provides data-driven AI video analysis services in South Korea. It offers X-AIVA, an AI video analysis platform; Uyuni, an AI standard platform based on Kubenetes; X-Labeller, a video data processing solution; X-GEN, a synthetic data generation solution; and Vidigo, a cloud-based AI video and speech analysis service. The company was founded in 2010 and is headquartered in Seoul, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

XIIlab Co reported revenue of 10.3B KRW in FY2025 versus 5.8B KRW in FY2021, a compound +15.5%/yr. Reported net income was −3.1B KRW in FY2025.

Growth Quality 7/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
10.3B KRW
Latest YoY
+13.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.2%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.6%
Avg. growth/yr (9Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+18.2%
Revenue +15.5%/yr
FY21 5.8B KRW
FY22 9.9B KRW
FY23 3.7B KRW
FY24 9.1B KRW
FY25 10.3B KRW
Net income
FY21 −2.1B KRW
FY22 −4.5B KRW
FY23 −6.5B KRW
FY24 −5.2B KRW
FY25 −3.1B KRW

189330 screens 82% overvalued. Compare with International Business Machines Corporation →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "XIIlab Co Fair Value". https://www.fairvalue-calculator.com/stock/189330

Peer Group

Information Technology Services · 476 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 39 · Bottom 25%
Fair Value upside −82% · Bottom 25%
Return on assets -14% · Bottom 25%
Net margin (TTM) -38% · Bottom 25%
Operating margin (TTM) -173% · Bottom 25%
Revenue growth 42% · Top 25%

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 21
FUTURE 100 · sector 30
PAST 0 · sector 36
HEALTH 0 · sector 97
DIVIDEND 0 · sector 37

VALUE 0: the price sits above our fair-value range.

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).

Stock Price Fair Value vs Fair Value
International Business Machines Corporation IBM $235.92 $143.90 -39%
Accenture plc ACNN 2,460 MXN 250.95 MXN -90%
Infosys Limited INFY ₹1,156 ₹1,457 +26%
HCL Technologies Limited HCLTECH ₹1,204 ₹1,230 +2%
Wipro Limited WIPRO ₹178.43 ₹226.81 +27%
Tech Mahindra Limited TECHM ₹1,455 ₹1,086 -25%
Samsung SDS Co 018260 199,300 KRW 196,390 KRW -1%
Persistent Systems Limited PERSISTENT ₹5,059 ₹2,364 -53%
Hyundai Autoever Corporation 307950 393,000 KRW 133,088 KRW -66%
Coforge Limited COFORGE ₹1,541 ₹702.84 -54%

Compare XIIlab Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is XIIlab Co (189330) overvalued or undervalued?
As of Jul 20, 2026, our model estimates a fair value of 2,495 KRW versus a price of 13,810 KRW, about −82% (overvalued).
What is the fair value of 189330?
Our model-based fair value for XIIlab Co is 2,495 KRW (as of Jul 20, 2026), built from audited fundamentals. The current price is 13,810 KRW.
What is the quality score of 189330?
XIIlab Co has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of XIIlab Co (189330)?
XIIlab Co reported trailing-twelve-month revenue of about 10.6B KRW (latest available figure, as of Jul 20, 2026).
What is the net profit margin of 189330?
The net profit margin of XIIlab Co is about -38.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track XIIlab Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.